IOL Chemicals and Pharmaceuticals Ltd receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III

European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product "Pantoprazole Sodium Sesquihydrate Process-III" on 14th October 2025.

Pantoprazole sodium is a proton pump inhibitor (PPI) that reduces stomach acid and is used to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals EDQM Certificate PantoprazoleSodiumSesquihydrateProcess3